Ascorbic Acid and Rates of Cognitive Decline in Alzheimer's Disease
Department of Neurology, Oregon Health & Science University, Portland, OR, USA.Journal of Alzheimer's disease: JAD (Impact Factor: 4.15). 02/2009; 16(1):93-8. DOI: 10.3233/JAD-2009-0923
The brain maintains high levels of ascorbic acid (AA) despite a concentration gradient favoring diffusion from brain to peripheral tissues. Dietary antioxidants, including AA, appear to modify the risk of Alzheimer's disease (AD). The objective of this study was to test the hypothesis that neurodegeneration in AD is modified by brain levels of AA. Thirty-two patients with mild to moderate AD participated in a biomarker study involving standardized clinical assessments over one year. Cerebrospinal fluid (CSF) and serum were collected at baseline for AA and albumin content. Cognitive measures were collected at baseline and one year. CSF and plasma AA failed to predict cognitive decline independently, however, CSF: plasma AA ratio did. After adding CSF Albumin Index (an established marker of blood-brain barrier integrity) to the regression models the effect of CSF: plasma AA ratio as a predictor of cognitive decline was weakened. CSF: plasma AA ratio predicts rate of decline in AD. This relationship may indicate that the CSF: plasma AA ratio is an index of AA availability to the brain or may be an artifact of a relationship between blood-brain barrier impairment and neurodegeneration.
Get notified about updates to this publicationFollow publication
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
[Show abstract] [Hide abstract] ABSTRACT: Objectives Vitamin C is a major antioxidant and also known as a neuromodulator in dopaminergic neurons. To investigate the association between lymphocyte and plasma vitamin C levels in various stages of Parkinson’s disease (PD). Methods Sixty-two subjects with PD (71 ± 8.8 years of age [mean ± SD]) being treated at Shizuoka General Hospital from December 2007 to August 2013 were consecutively recruited. PD severity was classified using the Hoehn-Yahr staging scale. Fasting blood samples were collected, and plasma/lymphocyte vitamin C levels were measured. The association between PD severity and vitamin C levels was estimated by ordinal logistic regression with confounding variables. Results The distribution of Hoehn-Yahr stages in subjects was as follows: stage I, n=7; II, n=28; III, n=16; IV, n=11. Lymphocyte vitamin C levels in subjects with severe PD was significantly lower (OR, 0.87; 95% CI, 0.80-0.97; p < 0.01) compared to those in subjects at less severe stages. Plasma vitamin C levels also tended to be lower in subjects with severe PD; however, this was not significant (OR, 0.98; 95% CI, 0.96-1.00; p = 0.09). Conclusions Our findings suggest that lymphocyte vitamin C levels in the peripheral blood may be a potentially useful biomarker for the progression of PD.
- "In this study, we demonstrated that lymphocyte vitamin C levels were significantly lower in patients with severe PD, and that there was a linear correlation between plasma and lymphocyte vitamin C levels. Correlations between vitamin C levels in the cerebrospinal fluid and peripheral blood have been reported ; we collected peripheral blood samples from participants with PD who were in fasting state. However, significant differences among PD stages were only observed in lymphocyte vitamin C levels. "
[Show abstract] [Hide abstract] ABSTRACT: We and other investigators have postulated deterioration of essential choroid plexus (CP) functions in some elderly and especially Alzheimer's disease patients based on apparent anatomical, histological and pathological changes in CP. We have termed this putative phenomenon CP failure. By focusing on four essential energy-requiring CP functions, specifically ascorbic acid (AA) and folate transport from blood into CSF, transthyretin synthesis and secretion into CSF, and electrolyte/acid--base balance in CSF, we were able to evaluate the hypothesis of CP failure by reviewing definitive human data. In both healthy elderly and Alzheimer's disease patients, the CP functions normally to transport AA and folates actively from blood into CSF, synthesize and secrete transthyretin into CSF, and maintain CSF acid--base balance and ion concentrations. These human CSF compositional data provide no support for the notion of CP failure in elderly humans and Alzheimer's disease patients.
- "As noted in Table 1, the mean plasma concentration in the Alzheimer’s patients was 31% lower than in age and sex-matched controls, presumably due to less AA in their dietary intake. In a separate uncontrolled study of 32 Alzheimer’s patients, Bowman et al. found a mean CSF/plasma ratio of 4.0 ± 0.3 (SEM)– confirming the findings summarized in Table 1. Collectively, these data provide no support for abnormal AA transport function in CP of elderly or Alzheimer’s patients. "
[Show abstract] [Hide abstract] ABSTRACT: This narrative review appraises the human and animal studies implicating ascorbic acid (AA) in normal cognitive function and Alzheimer's disease. A research framework for how nutrition affects brain aging is proposed with emphasis on AA intake, status, metabolism, and transport into brain tissue. A final synopsis highlights areas for future research regarding AA nourishment and healthy brain aging.
- "¼ 0.001) and plasma (P ¼ 0.002) and CSF (P ¼ 0.038) were lower in AD. All subjects were well-nourished and without vascular disease 18 Ctls (MMSE 27), 20 AD (MMSE 16) Women Age-matched (75–85 years) Cross sectional Bowman et al.  32 41 6 30 129 6 52 4.0 6 1.6 Higher CSF: plasma AA ratio associated with slower cognitive decline over 1 year (age, gender, education, apoEe4, and cognitive function at baseline adjusted P ¼ 0.025). Interaction between CSF AA ratio and BBB integrity identified AD (MMSE 19 6 5) Men/women Mean age 71 years Prospective "